PERIO-01: Initial Safety Experience and Immunologic Effects of a Class C TLR9 Agonist Using Pressure-Enabled Drug Delivery in a Phase 1 Trial of Hepatic Arterial Infusion of SD-101+/- Checkpoint Inhibition in Metastatic Uveal Melanoma
Cancer Research(2023)
Key words
Intraocular Chemotherapy,Uveal Melanoma
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined